Revolution Medicines Earnings Preview
Portfolio Pulse from Benzinga Insights
Revolution Medicines (NASDAQ:RVMD) is set to release its latest quarterly earnings report on Tuesday, 2023-08-08. Analysts estimate an earnings per share (EPS) of $-0.81. The company's past performance shows a trend of beating EPS estimates, which has often led to an increase in share price. The stock is currently trading at $31.21 and has seen a 30.01% increase over the last 52-week period.
August 07, 2023 | 2:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Revolution Medicines is expected to release its earnings report with an estimated EPS of $-0.81. The company has a history of beating EPS estimates, which could potentially lead to a positive impact on the stock price.
Revolution Medicines has a history of beating EPS estimates, which has often led to an increase in the share price. If the company beats the EPS estimate again, it could potentially lead to a positive impact on the stock price. Additionally, the stock has seen a 30.01% increase over the last 52-week period, indicating a positive sentiment among long-term shareholders.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100